Lv1
60 积分 2025-08-20 加入
Orforglipron compared with dapagliflozin in adults with type 2 diabetes and inadequate glycaemic control with metformin (ACHIEVE-2): a multicentre, randomised, non-inferiority, open-label, phase 3 trial
15天前
已完结
Efficacy and safety of co-administered cagrilintide and semaglutide versus semaglutide alone in adults with overweight or obesity with or without type 2 diabetes in Japan and Taiwan (REDEFINE 5): a multicentre, randomised, active-controlled, phase 3a trial
1个月前
已完结
Screening Children for Early-Stage Type 1 Diabetes
1个月前
已完结
Evolocumab to Reduce First Major Cardiovascular Events in Patients Without Known Significant Atherosclerosis and With Diabetes
1个月前
已完结
Advanced delivery systems for oxygen therapeutics: center around red blood cells
1个月前
已完结
Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes
2个月前
已完结
Medical diagnosis based on artificial intelligence and decision support system in the management of health development
3个月前
已完结
Cardiorespiratory interactions during the transitional period in extremely preterm infants: a narrative review
3个月前
已完结
Expanding the Potential Treatment of Thyroid Eye Disease
3个月前
已完结
IGF-1R Inhibitor IBI311 for the Treatment of Active Thyroid Eye Disease in Chinese Patients
3个月前
已完结